Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

Several clinical trials have shown promising efficacy of pegylated interferon (Peg-IFN) in the first- and second-line polycythemia vera (PV) and essential thrombocythemia (ET). However, the efficacy and safety of Peg-IFN in the real world have rarely been reported. Hence, we conducted a prospective,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yingxin Sun, Yifeng Cai, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Qian Wang, Depei Wu, Suning Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-12-01
coleção:	Frontiers in Oncology
Assuntos:	polycythemia vera essential thrombocythemia hematological response molecular response myeloproliferative neoplasms pegylated interferon alpha-2b
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.797825/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!